These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35106914)

  • 21. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease.
    Chan HH; Koh RY; Lim CL; Leong CO
    Curr Alzheimer Res; 2019; 16(10):907-918. PubMed ID: 31642777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK1/RIPK3-Mediated Necroptosis is Involved in Sevoflurane-Induced Neonatal Neurotoxicity in the Rat Hippocampus.
    Xu R; Zhu Y; Jia J; Li WX; Lu Y
    Cell Mol Neurobiol; 2022 Oct; 42(7):2235-2244. PubMed ID: 33991280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Regulation of RIPK1 and Necroptosis.
    Xu D; Zou C; Yuan J
    Annu Rev Genet; 2021 Nov; 55():235-263. PubMed ID: 34813352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
    J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
    Lusthaus M; Mazkereth N; Donin N; Fishelson Z
    Front Immunol; 2018; 9():306. PubMed ID: 29527209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis.
    Liu S; Li Y; Choi HMC; Sarkar C; Koh EY; Wu J; Lipinski MM
    Cell Death Dis; 2018 May; 9(5):476. PubMed ID: 29686269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis.
    Newton K; Wickliffe KE; Dugger DL; Maltzman A; Roose-Girma M; Dohse M; Kőműves L; Webster JD; Dixit VM
    Nature; 2019 Oct; 574(7778):428-431. PubMed ID: 31511692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer.
    Lin P; Lin C; He R; Chen H; Teng Z; Yao H; Liu S; Hoffman RM; Ye J; Zhu G
    Cell Death Dis; 2023 Jan; 14(1):6. PubMed ID: 36604411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia.
    Veli Ö; Kaya Ö; Varanda AB; Hildebrandt X; Xiao P; Estornes Y; Poggenberg M; Wang Y; Pasparakis M; Bertrand MJM; Walczak H; Annibaldi A; Cardozo AK; Peltzer N
    Mol Metab; 2024 Sep; 87():101988. PubMed ID: 39004142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1.
    Wang ZW; Zou FM; Wang AL; Yang J; Jin R; Wang BL; Shen LJ; Qi S; Liu J; Liu J; Wang WC; Liu QS
    Acta Pharmacol Sin; 2023 Apr; 44(4):801-810. PubMed ID: 36216899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
    Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
    Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer.
    Lin SS; Chang TM; Wei AI; Lee CW; Lin ZC; Chiang YC; Chi MC; Liu JF
    Aging (Albany NY); 2023 Dec; 15(24):14900-14914. PubMed ID: 38126996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment.
    Li S; Qu L; Wang X; Kong L
    Pharmacol Ther; 2022 Mar; 231():107979. PubMed ID: 34480965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.